How to Cite
Abstract
The state of the viscosity of erythrocyte membranes in breast cancer patients (68 - in menopause and 32 - with saved menstrual cycle) was studied in comparison with the content of steroid hormone receptors in the tumor tissue and the age of patients. It is showed that the less hormone dependence of the tumor the higher viscosity of erythrocyte membranes that manifested by a decrease in the coefficient of eximerization (CE) of pyrene in the protein/lipid and in particular, lipid/lipid membrane layers. Increasing CE of pyrene in lipid/lipid layer of erythrocyte membranes above 1.7 units, reflecting a decline in their microviscosity, could be considered as an additional extra-tumor criterion for identification of the tumor as of hormone dependent type.References
Берштейн Л.М. Гормональный канцерогенез. - СПб., Наука, - 2000. - С. 199.
Горошинская И.А., Голотина Л.Ю., Горло Е.И. и др. Изменение микровязкости мембран лимфоцитов и эритроцитов крови у онкологических больных// Вопр. мед. химии. - 1999. - Т. 45. - № 1. - С. 53-57.
Корман Д.Б., Потапов С.Л., Шамаев В.И. и др. Ненасыщенные липиды крови у больных раком молочной железы // Известия АН. Серия биологическая. - 1992. - № 2. - С. 206-214.
Новицкий В.В., Рязанцева Н.В., Степовая Е.А. и др. Молекулярные нарушения мембраны эритроцитов при патологии разного генеза являются типовой реакцией организма: контуры проблемы // Бюлл. сиб. Мед. - 2006. - № 2. - С. 62-69
Новицкий В.В., Степовая Е.А., Гольдберг В.Е. и др. Эритроциты и злокачественные новообразования. - Томск. - STT, - 2000. - С. 288.
Панин Л.Е., Бутусова В.Н., Рязанцева Н.В. и др. Влияние липопротеинов крови и аполипопротеинов А-I, С и Е на микровязкостные свойства мембран эритроцитов // Бюлл. эксперим. биол. и мед. - 2009. - Т. 148. - № 9. - С. 273-276.
Семиглазов В.Ф., Палтуев Р.М., Семиглазова Т.Ю. и др. Опухоли репродуктивной системы. Клинические рекомендации по диагностике и лечению рака молочной железы. - СПб., - 2012. - С. 234.
Степовая Е.А., Новицкий В.В., Рязанцева Н.В. и др. Структура и свойства липидного бислоя мембран эритроцитов у больных со злокачественными новообразованиями // Бюл. эксперим. биол. и мед. - 2003. - Т. 136. - № 11. - С. 553-557.
Alba E., Calvo L., Albanell J. et al. Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study // Oncology. - 2012. - Vol. 23 (12). - P. 3069-3074.
Brouckaert O., Paridaens R., Floris G. et al. A. critical review: why assessment of steroid hormone receptors in breast cancer should be quantitative // Ann. Oncol. - 2013. - Vol. 24. (1). - P. 47-53.
Cho Y.A., Sung M.K., Yeon J.Y. et al. Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype// Cancer Res Treat. - 2013. - Vol. 45 (3). - P. 210-219.
Connor A.E., Baumgartner R.N., Pinkston C., Baumgartner K.B. Obesity and risk of breast cancer mortality in Hispanic and Njn-Hispanic white women: the New Mexico Women’s Health Study // J.Womens Health. - 2013. - Vol. 22 (4). - P. 368-377.
Contiero P., Berrino F., Tagliabue G. et al. Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study // Breast Cancer Res Treat. - 2013. - Vol. 138 (3). - P. 951-959.
Dodge J.T., Mitchell C., Hanahan D.J. et al. Tre preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes // Archiv. Biochem. Biophys. - 1963. - Vol. 100. - P. 119-130.
Forte V., Pandey A., Abdelmessih R., Forte G. et al. Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer // Cardiorenal Med. - 2012. - Vol. 2. - P. 143-162.
Hammond M.E., Hayes D.F., Wolff A.C. et al. American Society of Clinical Oncology / College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer // J. Oncol Pract. - 2010. - Vol. 64. - P. 195-197.
Islam T., Matsuo K., Ito H., Hosono S. et al. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women // Ann Oncol. - 2012. - Vol. 23 (9). - P. 2435-2441.
Kimura K., Tanaka S., Iwamoto M. et al. Association between body mass index and breast cancer intrinsic subtypes in Japanese women // Exp Ther Med. - 2012. - Vol. 4 (3). - P. 391-396.
Ligibel J.A., Strickler H.D. Obesity and its impact on breast cancer: tumor incidence, recurrence, survival and possible interventions // Am Soc Clin Oncol Educ Book. - 2013. - P. 52-59.
Lowry O.H., Rosenbrough N.J., Farr A.L. et al. Protein measurement with the Folin phenol reagent // J. Biol. Chem. - 1951. - Vol. 193. - P. 256-275.
Masuda N., Sagara Y., Kinoshita T., Iwata H. et al. Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial // Lancet Oncol. - 2012. - Vol. 13 (4). - P. 345-352.
Munsell M.F., Sprague B.L., Berry D.A. Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status // Epidemiol Rev. - 2014. - Vol. 36 (1). - Р. 114-136.
Pichard C., Plu-Bureau G., Neves E. et al., Insulin resistance, obesity and breast cancer risk // Maturitas. - 2008. - Vol. 60. - P. 19-30.
Phipps A.I., Malone K.E., Porter P.L. et al. Body Size and Risk of Luminal, HER2-Overexpressing, and TripleNegative Breast Cancer in Postmenopausal Women // Cancer Epidemiol Biomarkers Prev. - 2008. - Vol. 17. - P. 2078-2086.
Sueta A., Ito H.i, Islam T., Hosono S. et al. Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: A. case-control study in Japanese women // Springerplus. - 2012. - Vol. 1 (1). - P. 39.
Suzuki R., Orsini N., Saji S. et al. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis // Int J. Cancer. - 2009. - Vol. 124 (3). - P. 698-712.
Tsuda K. Insulin and membrane microviscosity of erythrocytes as risk factors for stroke // Stroke. - 2003. - Vol. 34 (12). - Р. 225-226.
Tsuda K. Roles of adiponectin and oxidative stress in the regulation of membrane microviscosity of red blood cells in hypertensive men-an electron spin resonance study // Journal of Obesity. - 2011. - Vol. 2011. - P. 54814.
Tsuda K., Nishio I. Leptin and membrane fluidity of erythrocytes in essential hypertension. An electron paramagnetic resonance investigation // Am J. Hypertens. - 2004. - Vol. 17 (4). - P. 375-379.
Valle A., Sastre-Serra J., Oliver J., Roca P. Chronic leptin treatment sensitizes MCF-7 breast cancer cells to estrogen // Cell Physiol Biochem. - 2011. - Vol. 28 (5). - P. 823-832.
Villarreal-Garza C. Shaw-Dulin R., Lara-Medina F. et al. Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients // Exp Diabetes Res. - 2012. - Vol. 2012 (732027). - P. 1-8.
Vrieling A., Buck K., Kaaks R., Chang-Claude J. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis // Breast Cancer Res Treat. - 2010. - Vol. 123(3). - P. 641-649.
Waczulikova I., Sikurova L., Carsky J. et al. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine // Gen Physiol Biophys. - 2000. - Vol. 19 (4). - P. 381-392.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...